Abstract
The aim of the study was to evaluate the effects of steroid administration under standardised
conditions in a range of patients both normal and with adrenal pathologies and to
review the impact on plasma catecholamines and metanephrines. Corticosteroid administration
has been linked to the development of hypertensive crises in patients with phaeochromocytoma,
however a mechanism for this is not fully understood. We aimed to add useful information
about the effect of steroids on levels of these hormones under usual circumstances.
A prospective, observational cohort study of 50 patients undergoing the low-dose dexamethasone
suppression test (LDDST) was undertaken. Additional blood samples were taken at the
start and end of the standard LDDST. Biochemical analysis was carried out for plasma
catecholamines and plasma free metanephrines. Demographic and hormonal data were acquired
from review of the notes or measured at baseline. No significant changes in plasma
catecholamines or metanephrines were seen at the end of the LDDST compared to baseline.
This was also true of subgroup analysis, divided by age, gender, or type of underlying
pathology. Our results suggest that hypertensive reaction responses, rare as they
are, are unlikely to be related to normal adrenal physiology. Thus LDDST is likely
to be safe under most circumstances, however caution should be exercised in patients
with adrenal masses with imaging characteristics compatible with phaeochromocytoma.
It may be prudent to defer glucocorticoid administration until functioning phaeochromocytoma
has been excluded biochemically.
Key words
steroid - hydrocortisone - phaeochromocytoma - adrenals - catecholamines - metanephrines
References
1
Lenders JW, Keiser HR, Goldstein D, Willemsen JJ, Friberg P, Jacobs MC, Kloppenborg PW,
Thien T, Eisenhofer G.
Plasma metanephrines in the diagnosis of pheochromocytoma.
Ann Intern Med.
1995;
123
101-109
2
Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K.
Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and
management.
Drug Saf.
2007;
30
1031-1062
3
Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G.
Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review
of the literature.
Eur J Endocrinol.
2008;
158
423-429
4
Takahashi N, Shimada T, Tanabe K, Yoshitomi H, Murakami Y, Ishibashi Y, Kikkawa R,
Yano S, Araki A, Inoue A.
Steroid-induced crisis and rhabdomyolysis in a patient with pheochromocytoma: A case
report and review.
Int J Cardiol.
2008;
DOI: doi: 10.1016/j.ijcard.2009.12.183
5
Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP.
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Endocr Rev.
1998;
19
101-143
6
Sharara-Chami RI, Joachim M, Pacak K, Majzoub JA.
Glucocorticoid treatment – effect on adrenal medullary catecholamine production.
Shock.
2010;
33
213-217
7
Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM.
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab.
2008;
93
1526-1540
8
Lenders JW, Willemsen JJ, Eisenhofer G, Ross HA, Pacak K, Timmers HJ, Sweep CG.
Is supine rest necessary before blood sampling for plasma metanephrines?.
Clin Chem.
2007;
53
352-354
9
Peaston RT, Graham KS, Chambers E, van der Molen JC, Ball S.
Performance of plasma free metanephrines measured by liquid chromatography-tandem
mass spectrometry in the diagnosis of pheochromocytoma.
Clin Chim Acta.
2010;
411
546-552
10
Lenders JW, Eisenhofer G, Mannelli M, Pacak K.
Phaeochromocytoma.
Lancet.
2005;
366
665-675
11
Wurtman RJ.
Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: hormonal
specificity and dose-response characteristics.
Endocrinology.
1966;
79
608-614
12
Goodman R, Edgar D, Thoenen H, Wechsler W, Herschman H.
Glucocorticoid induction of tyrosine hydroxylase in a continuous cell line of rat
pheochromocytoma.
J Cell Biol.
1978;
78
R1-R7
13
Critchley JA, Henderson CG, Moffat LE, Ungar A, Waite J, West CP.
Proceedings: The release of catecholamines from perfused canine adrenal glands by
corticosteroids.
J Physiol.
1976;
254
30P-31P
14
Park YS, Ha CY, Park CH, Kim KT.
Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine
release in chromaffin cells.
Endocrinology.
2008;
149
4921-4927
15
Wong S, Tan K, Carey KT, Fukushima A, Tiganis T, Cole TJ.
Glucocorticoids stimulate hepatic and renal catecholamine inactivation by direct rapid
induction of the dopamine sulfotransferase Sult1d1.
Endocrinology.
2010;
151
185-194
16
Wurtman RJ, Axelrod J.
Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids.
Science.
1965;
150
1464-1465
17
Wong DL, Siddall B, Wang W.
Hormonal control of rat adrenal phenylethanolamine N-methyltransferase. Enzyme activity,
the final critical pathway.
Neuropsychopharmacology.
1995;
13
223-234
18
Viskupic E, Kvetnansky R, Sabban EL, Fukuhara K, Weise VK, Kopin IJ, Schwartz JP.
Increase in rat adrenal phenylethanolamine N-methyltransferase mRNA level caused by
immobilization stress depends on intact pituitary-adrenocortical axis.
J Neurochem.
1994;
63
808-814
19
Betito K, Diorio J, Meaney MJ, Boksa P.
Adrenal phenylethanolamine N-methyltransferase induction in relation to glucocorticoid
receptor dynamics: evidence that acute exposure to high cortisol levels is sufficient
to induce the enzyme.
J Neurochem.
1992;
58
1853-1862
20
Betito K, Diorio J, Boksa P.
Brief cortisol exposure elevates adrenal phenylethanolamine N-methyltransferase after
a necessary lag period.
Eur J Pharmacol.
1993;
238
273-282
21
Tischler AS, Perlman RL, Morse GM, Sheard BE.
Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma
cell cultures.
J Neurochem.
1983;
40
364-370
22
Liu J, Heikkila P, Voutilainen R, Karonen SL, Kahri AI.
Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone;
regulation by glucocorticoids and nerve growth factor.
Eur J Endocrinol.
1994;
131
221-228
23
Pacak K, Eisenhofer G, Grossman A.
The incidentally discovered adrenal mass.
N Engl J Med.
2007;
356
2005
24
Young Jr WF.
Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.
Rev Endocr Metab Disord.
2007;
8
309-320
Correspondence
Dr. M. R. Druce
Department of Endocrinology
St Bartholomew's Hospital
London EC1A 7BE
United Kingdom
Phone: +44/203 465 5378
Fax: +44/203 465 6148
Email: m.r.druce@qmul.ac.uk